These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30161175)

  • 1. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
    Sacchi A; Tumino N; Grassi G; Casetti R; Cimini E; Bordoni V; Ammassari A; Antinori A; Agrati C
    PLoS One; 2018; 13(8):e0202920. PubMed ID: 30161175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery.
    Agrati C; Tumino N; Bordoni V; Pinnetti C; Sabatini A; Amendola A; Abbate I; Lorenzini P; Mondi A; Casetti R; Cimini E; Grassi G; Antinori A; Sacchi A
    Front Immunol; 2019; 10():1886. PubMed ID: 31440256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
    Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
    J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 5. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.
    Singh A; Rieber N
    Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
    Cassetta L; Bruderek K; Skrzeczynska-Moncznik J; Osiecka O; Hu X; Rundgren IM; Lin A; Santegoets K; Horzum U; Godinho-Santos A; Zelinskyy G; Garcia-Tellez T; Bjelica S; Taciak B; Kittang AO; Höing B; Lang S; Dixon M; Müller V; Utikal JS; Karakoç D; Yilmaz KB; Górka E; Bodnar L; Anastasiou OE; Bourgeois C; Badura R; Kapinska-Mrowiecka M; Gotic M; Ter Laan M; Kers-Rebel E; Król M; Santibañez JF; Müller-Trutwin M; Dittmer U; de Sousa AE; Esendağlı G; Adema G; Loré K; Ersvær E; Umansky V; Pollard JW; Cichy J; Brandau S
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32907925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
    Bruderek K; Schirrmann R; Brandau S
    Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Characterization and Isolation of Myeloid-Derived Suppressor Cells.
    Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
    Curr Protoc; 2022 Oct; 2(10):e561. PubMed ID: 36214619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples.
    Lee EJ; Jung S; Park KH; Park SI
    J Immunol Methods; 2022 Nov; 510():113348. PubMed ID: 36058258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer.
    Tavukcuoglu E; Horzum U; Yanik H; Uner A; Yoyen-Ermis D; Nural SK; Aydin B; Sokmensuer C; Karakoc D; Yilmaz KB; Hamaloglu E; Esendagli G
    Eur J Immunol; 2020 Dec; 50(12):2067-2074. PubMed ID: 32691408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
    Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
    Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
    Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
    [No Abstract]   [Full Text] [Related]  

  • 16. Brief Report: In cART-Treated HIV-Infected Patients, Immunologic Failure Is Associated With a High Myeloid-Derived Suppressor Cell Frequency.
    Grassi G; Notari S; Cicalini S; Casetti R; Cimini E; Bordoni V; Gagliardini R; Mazzotta V; Antinori A; Agrati C; Sacchi A
    J Acquir Immune Defic Syndr; 2024 Feb; 95(2):185-189. PubMed ID: 38211959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma.
    Sheng IY; Diaz-Montero CM; Rayman P; Wei W; Finke JH; Kim JS; Pavicic PG; Lamenza M; Company D; Stephenson A; Campbell S; Haber G; Lee B; Mian O; Gilligan TD; Rini BI; Garcia JA; Grivas P; Ornstein MC
    Target Oncol; 2020 Apr; 15(2):211-220. PubMed ID: 32207064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level.
    Tumino N; Bilotta MT; Pinnetti C; Ammassari A; Antinori A; Turchi F; Agrati C; Casetti R; Bordoni V; Cimini E; Abbate I; Capobianchi MR; Martini F; Sacchi A
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):575-582. PubMed ID: 28060224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
    Heuvers ME; Muskens F; Bezemer K; Lambers M; Dingemans AC; Groen HJM; Smit EF; Hoogsteden HC; Hegmans JPJJ; Aerts JGJV
    Lung Cancer; 2013 Sep; 81(3):468-474. PubMed ID: 23850196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.